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not obtain the legal support theywanted. Publicly systematic research ineugenics was advocated
by only a small group of people; names like those of the physicians Frets and Van Herwerden
often recur. Only after the First World War did a few organizations for anthropogenetics,
anthropology, and population studies amalgamate to be come the Dutch Eugenics Federation in
1930. The final 100 pages of the book are devoted to the wide range of negative and positive
eugenicist measures proposed, ranging from screening for VD to isolation or sterilization.
Noordman discusses various parliamentary and media debates, again carefully displaying the
multi-layered political, professional, and ethical motivations of their participants.
This is the first comprehensive study ofthe subject in The Netherlands in recent times. Many
of its themes could be further developed: one, as the author himself points out, is the relation
between the degenerationist and eugenicist arguments; another is the presence, here maybe
slightly underrated, of racial arguments in Dutch medical writings.
G. van Heteren, University ofNijmegen
JOAN AUSTOKER, A history of the Imperial Cancer Research Fund 1902-1986, Oxford
University Press, 1988, 8vo, pp. xvii, 375, illus., £40.00.
Writing the history ofan institution presents problems. To balance its scientific achievements
with developments elsewhere, to assess the relative contributions ofa succession ofdirectorsand
of individual scientific staff and, in the case of a charity, to relate scientific endeavour to the
availability offinancial support are tasks that would daunt the faint-hearted. In A historyofthe
Imperial Cancer Research Fund, Joan Austoker has achieved a synthesis that demonstrates
formidable scholarship. The book has been extensively researched and the footnotes soprolific
that on some pages they exceed the text.
The origins ofthe cancer research are to be found in the nineteenth century but it was notuntil
the early decades ofthe twentieth that the foundations ofmodern experimental cancer research
were laid. The Imperial Cancer Research Fund, founded in 1902, was the first attempt in this
country to set up a national body to organize and fund cancer research. Itssubsequent success as
a research-funding body was not achieved without difficulty. In the early years there were
conflicts with the Medical Research Council and the Department ofHealth, and the foundation
ofarival bodyduringthe 1920s, the British Empire CancerCampaign(nowthe Cancer Research
Campaign) did not help matters. There were, furthermore, differences between scientists who
believed that the future lay in the experimental research laboratory, and those clinicians who
sought to encourage the study of the patient. Nevertheless, a succession of Directors and
Chairmen ofCouncil laboured manfully through the years between the World Wars, although
theperiod 1933-9was to beassociatedwithdisillusion anddissension that necessitated extensive
reconstruction. Since the late 1950s, however, new initiatives were undertaken, new buildings
opened in Lincoln's Inn Fields, and the way set for the modern era. It was undoubtedly during
the years of Sir Michael Stoker's direction of the Fund's scientific activities that a centre of
international excellence was established. It was also during this period that the policy of
founding extramural Units in the Universities and medical schools was formulated. At St
Bartholomew's Hospital, as a result of the tireless activities of Gordon Hamilton Fairley and
with support from the Fund, the speciality ofmedical oncology emerged in this country. The
book begins with a perceptive introduction by Sir Angus Ogilvy, who has done so much as
President of the Fund since 1964, and there is an epilogue looking to the future by the present
Director of Research, Sir Walter Bodmer.
There are moments when the reader may find it difficult to see the wood for the trees, such is
the mass of information obtained by generations of dedicated workers in cancer research,
retailed in painstaking detail by Dr Austoker. But there is no doubt that this work is a major
contribution to the history ofcontemporary medical science and it will remain the authoritative
account of the history of the Fund.
Sir Christopher Booth, Royal College of Physicians
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